Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.
Can a blood test predict Alzheimer’s? New research shows the pTau217 biomarker detects amyloid accumulation and cognitive ...
A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...
Boston scientists say a routine blood draw might spot the earliest changes of Alzheimer’s long before the brain lights up on ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, April 15, 2026 (HealthDay News) — A blood test can predict Alzheimer’s ...
A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an ...
A new study shows that a blood test measuring plasma phosphorylated tau 217 (pTau217) can identify Alzheimer’s disease risk years before brain scans detect changes. Researchers found elevated pTau217 ...